1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

This listing may be outdated. Verify details at the official source before applying.

Find similar grants

ActiveU.S. Army Medical Research Acquisition Activity · 2026

DoW Breast Cancer, Breakthrough Award Level 3

Quick Facts

Agency: U.S. Army Medical Research Acquisition Activity
Funding: Case Dependent
Deadline: Check Source
Status: Active
Eligibility: Organizations, not individuals.

About This Grant

DoW Breast Cancer, Breakthrough Award Level 3 is sponsored by U.S. Army Medical Research Acquisition Activity. This opportunity supports mission-aligned projects and measurable outcomes.

View Original RFP

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Official Opportunity Details

Extracted from the official opportunity page/RFP to help you evaluate fit faster.

Opportunity Listing - DoW Breast Cancer, Breakthrough Award Level 3 DoW Breast Cancer, Breakthrough Award Level 3 Agency: Defense Health Agency Contracting Activity - DHACA Assistance Listings: 12. 420 -- Military Medical Research and Development Last Updated: May 13, 2026 View version history on Grants.

gov Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.

Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope.

This program announcement discusses the Breakthrough Award Level 3. · For this funding mechanism, small-scale clinical trials are allowed but not required. Applications proposing projects with a clinical trial should be submitted under the Clinical Trial option.

· The research team must include two or more breast cancer consumer advocates. · This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage.

Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal. Grantor contact information File name Description Last updated HT942526BCRPBTA3_GG.

pdf FY26 BCRP BTA3 Program Announcement Link to additional information Closing: September 30, 2026 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Science technology and other research and development Your account requires additional identity verification.

Eligibility Requirements

Organizations, not individuals.

Frequently Asked Questions

Who can apply for DoW Breast Cancer, Breakthrough Award Level 3?

According to the current listing, eligibility includes: Organizations, not individuals. Confirm the full requirements in the official notice before applying.

Who funds DoW Breast Cancer, Breakthrough Award Level 3?

DoW Breast Cancer, Breakthrough Award Level 3 is funded by U.S. Army Medical Research Acquisition Activity. Verify program details on the funder's official page before applying.

How do I apply for DoW Breast Cancer, Breakthrough Award Level 3?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

U.S. Army Medical Research Acquisition Activity Grant Writing Tips

NIH Signed a 10-Year Agreement That Could Move $2 Billion of Infectious Disease Research to the Pentagon

The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.

Read article

New York Cut Its Community Center Renovation Pool From $35 Million to $5 Million and Raised the Passing Score to 85. NY BRICKS Round 2 Is a Different Program.

The August 31 RFA for Round 2 of NY BRICKS makes $75 million available with a December 7 deadline — but the eligibility threshold jumped from 20 points to 31, the minimum award score went from 70 to 85, property acquisition became an ineligible use, and the renovation set-aside shrank 86 percent.

Read article

Illinois Is Handing Out $37.5 Million in Park Grants by August 31 — and Covering 100 Percent of the Cost in Distressed Communities, Which Is the Part Nobody Uses

IDNR's OSLAD program closes at 5:00 p.m. on August 31, 2026, with $37.5 million available, a $1,125,000 ceiling for land acquisition and $600,000 for development. The standard deal is 50/50. The deal that matters for small towns is the full-funding provision for economically distressed communities — and the thing that disqualifies applicants is not the project, it is GATA prequalification.

Read article